About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Cancer Control
›
Top Articles
Cancer Control
Hematology
,
Oncology
2.2
(top 8%)
Impact Factor
2.4
(top 8%)
extended IF
73
(top 5%)
H-Index
507
authors
1.8K
papers
30.2K
citations
4.5K
citing journals
20.2K
citing authors
Most Cited Articles of Cancer Control
Title
Year
Citations
Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein
2003
750
Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancers
2003
237
Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
2017
235
The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies
2009
232
Solitary fibrous tumor of the pleura
2006
221
EGFR targeting of solid tumors
2007
220
Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers
2002
206
Teachable moments for promoting smoking cessation: the context of cancer care and survivorship
2003
182
Celecoxib: a specific COX-2 inhibitor with anticancer properties
2002
181
Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea
2007
180
Endometrial cancer and Lynch syndrome: clinical and pathologic considerations
2009
170
Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer
2016
169
Mechanisms of primary and secondary resistance to imatinib in chronic myeloid leukemia
2009
165
Intraocular lymphoma: update on diagnosis and management
2004
158
A review of triple-negative breast cancer
2010
152
Malignant pleural mesothelioma: a comprehensive review
2006
152
Yoga for cancer patients and survivors
2005
151
Interaction between comorbidity and cancer
2007
147
Poorly differentiated and anaplastic thyroid cancer
2006
144
Aging, frailty, and chemotherapy
2007
143
Lessons learned from community-based participatory research in Indian country
2005
140
Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment
2014
139
Diagnosis, classification, and management of soft tissue sarcomas
2005
138
Epistemologic inquiries in evidence-based medicine
2009
131
Prognostic indicators in differentiated thyroid carcinoma
2000
128
previous
2001
2002
2003
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.